Publication | Open Access
A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents Recurrent<i>Clostridium difficile</i>Infection
310
Citations
35
References
2016
Year
SER-109 successfully prevented CDI and had a favorable safety profile, supporting a novel microbiome-based intervention as a potential therapy for recurrent CDI.
| Year | Citations | |
|---|---|---|
Page 1
Page 1